Fiorentino, F., Canali, B., Morelli, P. and Demma, F. 2023. Brentuximab vedotin in combination with doxorubicin, vinblastine and dacarbazine for first-line treatment of stage IV HL: cost impact on subsequent lines in Italy. AboutOpen. 10, 1 (Jan. 2023), 6–12. DOI:https://doi.org/10.33393/ao.2023.2486.